Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

Go back to Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10
(NASDAQ: AXSM) Delayed: 214.28 +2.31 (1.09%)
Previous Close $211.97    52 Week High $15.74 
Open $215.59    52 Week Low $5.37 
Day High $216.47    P/E N/A 
Day Low $208.63    EPS $0.00 
Volume 681,464